ArticleProceedings of the National Academy of Sciences of the United States of America2017

Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy.

Yin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.